Two forms of the archaeal intron-encoded site-speci®c endonuclease I-DmoI, namely I-DmoIc and I-DmoIl, have been puri®ed and crystallized. Crystals of I-DmoIc are rod-shaped and diffract to 3.0 A Ê resolution, but further analysis was hampered by twinning. Crystals of I-DmoIl, which is a six-amino-acid C-terminal truncation of I-DmoIc, are plate shaped and belong to space group C2 with cell parameters a = 93.72, b = 37.03, c = 55.56 A Ê , = 113.4 , with one molecule per asymmetric unit (V m = 2.01 A Ê 3 Da À1 ). The crystals diffract to at least 2.3 A Ê resolution. A complete native data set has been measured and structure determination is on-going.
Introduction
I-DmoI is a site-speci®c endonuclease encoded by an archaeal intron present in the 23S rRNA gene of the hyperthermophile Desulfurococcus mobilis (Kjems & Garrett, 1985; Dalgaard et al., 1993) . This enzyme is a member of a family of homing endonucleases characterized by the presence of a conserved repeated dodecapeptide motif named LAGLIDADG (Dalgaard et al., 1997; Belfort & Roberts, 1997) . I-DmoI has been shown to be involved in promoting the mobility of the intron that encodes it (Aagaard et al., 1995) , in a similar fashion to other members of this family encoded by group I introns and inteins (Jacquier & Dujon, 1985; Gimble & Thorner, 1992) . I-DmoI recognizes and cleaves a 14±20 basepair DNA sequence present in an intron-minus allele, generating a four-base-pair 3 H -hydroxyl overhang (Dalgaard et al., 1994; Aagaard et al., 1997) . The break initiates a recombinational event that utilizes the intron-containing allele as donor, leading to the propagation of the intron to the new allele.
The archaeal intron that encodes I-DmoI is unusual in that it cyclizes after splicing. Since the open reading frame encoding I-DmoI does not contain a stop codon 3 H to the start codon within the intron sequence, several different forms of I-DmoI can theoretically be expressed in vivo. These include translation products of the pre-rRNA, as well as of the linear and circular introns. Two of the forms, I-DmoIl (linear intronencoded) and I-DmoIc (circular intron-encoded), which differ in length by six amino acids, have been shown to possess the same site-speci®c endonuclease activity (Dalgaard et al., 1993) and were used in crystallization trials.
Experimental

Puri®cation
Both forms of I-DmoI were puri®ed to near homogeneity after overexpression in Escherichia coli as previously described (Dalgaard et al., 1994) . Brie¯y, the puri®cation was performed as follows. The enzyme was overexpressed using the pT7 expression system (Studier & Moffatt, 1986) and cells were disrupted by sonication. The enzyme was puri®ed by ammonium sulfate fractionation, followed by chromatography using heparin-af®nity and phenyl-Sepharose columns. After puri®cation the enzyme was concentrated over a 1 ml heparin column (Hitrap Heparin, Pharmacia). Pooled fractions from the phenyl-Sepharose column were applied directly to the heparin column and eluted with a step gradient from 0.5 to 1.5 M NaCl. The enzyme-containing fractions were dialysed against 10 mM Tris±HCl pH 8.0, 1 mM DTT, 10% ethylene glycol and 0.5 M NaCl. The ®nal concentrations were approximately 10 mg ml À1 . The purity and molecular weight were veri®ed using electrospray mass spectrometry: 22 609 Da for I-DmoIc and 22 003 Da for I-DmoIl. The secondary structure composition of I-DmoIc was estimated from a circular dichroism spectrum. The spectrum was obtained using a J-720 Spectropolarimeter (JASCO) that had been calibrated with aminocamphorsulfonate using a 0.5 mm path length. The sample contained 0.5 mg ml À1 I-DmoIc in 20 mM Tris±HCl and 100 mM NH 4 OAc. Using the method of Yang et al. (1986) , the composition was estimated to be 50.2% -sheet, 28.1% -helix, 21.6% random coil and 0% -turn.
Crystallization
Crystals were grown by hanging-drop vapor-diffusion methods. An initial screening for crystallization conditions was performed with the sparse-matrix sampling protocol (Jancarik & Kim, 1991) , using drops containing 2 ml protein solution and 2 ml precipitating solution equilibrated against 800 ml of reservoir solution at 293 K. For I-DmoIc, small needles formed after one day under several conditions of the Crystal Screen I (Hampton Research) kit, all of which contained PEG as the primary precipitating agent. After three to four weeks, several high-salt solutions also yielded needle-shaped crystals. Optimization experiments led to the following conditions for crystallization: drops containing 3 ml protein at 10 mg ml À1 in 5 mM Tris±HCl pH 8.0, 150 mM NaCl, 10% ethylene glycol, 1 mM DTT and 3 ml precipitating buffer were equilibrated against 1 ml of precipitating buffer containing 2±3% PEG 3350, 1±1.2 M sodium acetate, 10% ethylene glycol, 1% 2-methyl-2,4-pentanediol, 50 mM Na + , K + phosphate pH 8. experiments at 310 K and by stepwise lowering of the temperature to 293 K over a period of four weeks. The crystals are rod-shaped and diffract to at least 3.0 A Ê resolution, but further analysis was hampered by twinning problems.
For I-DmoIl, initial crystallization trials with the Crystal Screen kit yielded small crystals from 30% PEG 3350, 200 mM Li 2 SO 4 in 100 mM Tris±HCl pH 8.5 using protein at approximately 10 mg ml À1 in 5 mM Tris±HCl pH 8.0, 150 mM NaCl, 10% ethylene glycol and 1 mM DTT. Optimization experiments resulted in reproducible large crystals from drops containing 4 ml protein solution as described above, 4 ml precipitating buffer and 1 ml of 20 mM n-octyl--glucopyranoside equilibrated against 1 ml of a precipitating buffer consisting of 30% PEG 3350, 200 mM sodium acetate in 100 mM Tris±HCl pH 8.5. Plate-shaped crystals, as shown in Fig. 1 , grow in 2±5 days to dimensions of 0.5 Â 0.3 Â 0.1 mm.
Results and discussion
X-ray diffraction data were measured on a Rigaku R-AXIS IIc detector equipped with mirror optics and a liquid-nitrogen low-temperature device. The crystal was¯ash-cooled to approximately 130 K. No additional cryoprotectant was required. The I-DmoIl crystals belong to the monoclinic space group C2 with cell parameters a = 93.72, b = 37.03, c = 55.56 A Ê , = 113.4 and V = 176 960 A Ê 3 . With a molecular weight of 22 003 Da and one molecule per asymmetric unit, V m is 2.01 A Ê 3 Da À1 , corresponding to a solvent content of 33.3% (Matthews, 1968) . A 2.33 A Ê native data set was measured using a crystal with approximate dimensions 0.4 Â 0.3 Â 0.1 mm. The data were processed and scaled with the BIOTEX package (Molecular Structure Corporation). Details of the datareduction statistics are listed in Table 1 .
The structures of two other LAGLIDADG proteins, the homing endonuclease I-CreI (Heath et al., 1997) and the intein PI-SceI (Duan et al., 1997) , were recently published. I-CreI is unusual in that it contains only one LAGLIDADG motif and functions as a homodimer. The structure of I-CreI shows the two monomers related by a crystallographic twofold rotation axis. PI-SceI consists of a protein-splicing domain and an endonuclease domain. The endonuclease domain contains two LADLIDADG motifs and has a two-subdomain fold. The overall topology of each subdomain resembles that of an I-CreI monomer but the subdomains differ signi®cantly in the dimensions and relative orientations of some of the secondary elements, resulting in an asymmetric structure. I-DmoI differs from both these enzymes since it contains two LAGLIDADG motifs but no protein-splicing domain. A self-rotation search, using the program AMoRe (Navaza, 1994), was performed for I-DmoI. Since no twofold rotation peak other than the crystallographic rotation axis could be detected, the overall structure of I-DmoI is likely to be more similar to that of the endonuclease domain of PI-SceI than to that of the I-CreI dimer. Molecular-replacement calculations aimed at determining the structure of I-DmoI, using the structure of I-CreI as a model, have not yielded any valid solutions. This may be explained by the fact that the I-CreI dimer is much larger than I-DmoI (276 compared with 187 residues) but is probably also a consequence of the anticipated lower symmetry of the latter. Therefore, the structure of I-DmoI will be determined by multiple isomorphous replacement or multiple anomalous diffraction (MAD) methods. Currently, at least two potential heavy-atom derivatives have been identi®ed; however, phasing attempts are hampered by non-isomorphism problems. Therefore, MAD phasing is the most likely to be successful.
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